Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →43
🟠 Elevated
🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128(a)(1) — Felony Conviction · Date: 07/20/2025 · State: AZ
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,077
Total Claims
$70K
Drug Cost
217
Beneficiaries
$324
Cost/Patient
Risk Score Breakdown 43/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+59%
Opioid rate vs peers
73.1% vs 45.9% avg
-33%
Cost per patient vs peers
$324 vs $483 avg
+33%
Brand preference vs peers
5.5% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider appears on the federal OIG exclusion list, meaning they have been formally barred from participating in federal healthcare programs due to fraud, patient abuse, licensing issues, or other misconduct. The fact that they still appear in active prescribing data is a significant concern.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
73.1%
Opioid Rate
787
Opioid Claims
$63K
Opioid Cost
26.7%
Long-Acting Rate
This provider's opioid prescribing rate of 73.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 59 claims · $42K
Generic: 1,018 claims · $28K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 28 | $38K |
| Oxycodone Hcl | 193 | $6,598 |
| Hydrocodone/Acetaminophen | 163 | $5,340 |
| Morphine Sulfate | 141 | $4,169 |
| Oxycodone Hcl/Acetaminophen | 120 | $3,680 |
| Fentanyl | 37 | $2,154 |
| Tramadol Hcl | 57 | $794 |
| Morphine Sulfate | 19 | $538 |
| Methylprednisolone | 59 | $486 |
| Pregabalin | 13 | $453 |
| Gabapentin | 28 | $428 |
| Baclofen | 32 | $411 |
| Tizanidine Hcl | 28 | $347 |
| Hydromorphone Hcl | 20 | $237 |
| Zolpidem Tartrate | 19 | $226 |
Prescribing Profile
16
Unique Drugs
43.0
Anomaly Score
Patient Profile
73
Avg Age
58%
Female
1.49
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data